专利信息

首页 1 2 3 4 5 6 下页尾页共 533 条记录, 当前第1/54页。

专利标题：Respiratory disease treatment

There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation which composition comprises a glitazone such as pioglitazone or rosiglitazone and one or more pharmaceutically acceptable carriers and/or excipients and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and a kit.

专利标题：D-pg derivative and its production and use

Rosiglitazone 5-ASA or structurally analogous Compounds according to the general formula (I): or Compounds according to the general formula (Ia): For the induction of CAMP expression in tissues having PPAR-gamma receptors. Such tissues include epithelia or mucosae tissue having PPAR-gamma receptors and of particular interest is CAMP expression in the gut.

专利标题：Composition for treating atherosclerosis and a preparation method thereof

专利权人：Kaohsiung Medical University;

Disclosed are a composition for preventing and treating atherosclerosis which includes chalcone compound. In particular the chalcone compound bound with 2-hydroxyl in ring A and 4′-methyoxy in ring B has versatile therapeutic potentials on anti-atherosclerosis by acting as PPARγ inducer p44/42 MAPK inhibitor and cell cycle blocker and does not show toxicity to human aortic smooth muscle cells (HASMCs). In addition the chalcone compound exhibits synergistic effect with the PPARγ...

专利标题：Novel use of pharmaceutical composition of thiazolidinedione medicines and 5-methyl tetrahydrofolic acid

专利权人：Ausa Pharmed Co., Ltd.;

专利标题：Inhibitor for hepatoma carcinoma cell and application in aspect of inhibiting tumor growth thereof

专利权人：Shanghai Cancer Institute;

专利标题：Novel capsule filled with rosiglitazone solid preparation and metformin solid preparation

专利标题：Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level

专利权人：NOVARTIS AG;

Abstract - 603255 Disclosed is the compound 2-(3-(cyclopropylmethyl)-2-oxo-imidazolidin-1-yl)-4-methyl-N-(pyridin-3-ylmethyl)thiazole-5-carboxamide or a pharmaceutically acceptable salt thereof. Further disclosed is a pharmaceutical composition comprising a therapeutically effective amount of the compound 2-(3-(cyclopropylmethyl)-2-oxoimidazolidin-1-yl)-4-methyl-N-(pyridin-3-ylmethyl)thiazole-5-carboxamide or a pharmaceutically acceptable salt thereof optionally in combination with a therapeutic...

专利标题：Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants

专利权人：Giuliani International Limited;

专利标题：A kind for the treatment of diabetes compound medicine that reduces the rosiglitazone side effect and preparation method thereof

当前查询条件: [药品] 包含 'Rosiglitazone'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. EA019339B1	2014/2/28	EA20110000305	2009/8/5
专利标题：Respiratory disease treatment 专利权人：Pulmagen Therapeutics (inflammation) Limited; There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation which composition comprises a glitazone such as pioglitazone or rosiglitazone and one or more pharmaceutically acceptable carriers and/or excipients and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and a kit.

2. CN103570586A	2014/2/12	CN20121285081	2012/8/6
专利标题：D-pg derivative and its production and use 专利权人：

3. JP5351772B2	2013/11/27	JP20090551194	2008/2/27
专利标题：专利权人： Rosiglitazone 5-ASA or structurally analogous Compounds according to the general formula (I): or Compounds according to the general formula (Ia): For the induction of CAMP expression in tissues having PPAR-gamma receptors. Such tissues include epithelia or mucosae tissue having PPAR-gamma receptors and of particular interest is CAMP expression in the gut.

4. TWI415600B	2013/11/21	TW20110128614	2011/8/10
专利标题：Composition for treating atherosclerosis and a preparation method thereof 专利权人：Kaohsiung Medical University; Disclosed are a composition for preventing and treating atherosclerosis which includes chalcone compound. In particular the chalcone compound bound with 2-hydroxyl in ring A and 4′-methyoxy in ring B has versatile therapeutic potentials on anti-atherosclerosis by acting as PPARγ inducer p44/42 MAPK inhibitor and cell cycle blocker and does not show toxicity to human aortic smooth muscle cells (HASMCs). In addition the chalcone compound exhibits synergistic effect with the PPARγ...

5. CN103393686A	2013/11/20	CN20131311051	2013/7/15
专利标题：Novel use of pharmaceutical composition of thiazolidinedione medicines and 5-methyl tetrahydrofolic acid 专利权人：Ausa Pharmed Co., Ltd.;

6. CN102940884B	2013/11/6	CN20121464985	2012/11/19
专利标题：Inhibitor for hepatoma carcinoma cell and application in aspect of inhibiting tumor growth thereof 专利权人：Shanghai Cancer Institute;

7. CN103356502A	2013/10/23	CN2012184643	2012/3/28
专利标题：Novel capsule filled with rosiglitazone solid preparation and metformin solid preparation 专利权人：Heilongjiang Fuhe Huaxing Pharmaceutical Group Co., Ltd.;

8. NZ598548A	2013/9/27	NZ20070598548	2007/8/13
专利标题：Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level 专利权人：NOVARTIS AG; Abstract - 603255 Disclosed is the compound 2-(3-(cyclopropylmethyl)-2-oxo-imidazolidin-1-yl)-4-methyl-N-(pyridin-3-ylmethyl)thiazole-5-carboxamide or a pharmaceutically acceptable salt thereof. Further disclosed is a pharmaceutical composition comprising a therapeutically effective amount of the compound 2-(3-(cyclopropylmethyl)-2-oxoimidazolidin-1-yl)-4-methyl-N-(pyridin-3-ylmethyl)thiazole-5-carboxamide or a pharmaceutically acceptable salt thereof optionally in combination with a therapeutic...

9. AU2008220762B2	2013/8/22	AU20080220762	2008/2/27
专利标题：Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants 专利权人：Giuliani International Limited; Rosiglitazone 5-ASA or structurally analogous Compounds according to the general formula (I): or Compounds according to the general formula (Ia): For the induction of CAMP expression in tissues having PPAR-gamma receptors. Such tissues include epithelia or mucosae tissue having PPAR-gamma receptors and of particular interest s CAMP expression in the gut

10. CN103251954A	2013/8/21	CN20131189925	2013/5/22
专利标题：A kind for the treatment of diabetes compound medicine that reduces the rosiglitazone side effect and preparation method thereof 专利权人：

下载范围

下载内容